抗精神病药物-话题@MedSci

#抗精神病药物#

1篇内容 | 1135人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2197425, encodeId=3a2a219e425dd, content=<a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a> <a href='/topic/show?id=b68e89442ba' target=_blank style='color:#2F92EE;'>#血清素#</a> <a href='/topic/show?id=fd9210499218' target=_blank style='color:#2F92EE;'>#5-HT2AR#</a>, objectTitle=Mol Psychiatry：抗精神病药物血清素 5-HT2A 受体的药理学指纹, objectType=article, longId=820646, objectId=669c820646f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697150741633_4754896.jpeg, objectUrl=/article/show_article.do?id=669c820646f7, replyNumber=0, likeNumber=11, createdTime=2024-04-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=669c820646f7, moduleTitle=Mol Psychiatry：抗精神病药物血清素 5-HT2A 受体的药理学指纹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=669c820646f7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181274, encodeId=d5ef21812e47c, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a> <a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a>, objectTitle=CGP医学前沿|精神分裂症的社区治疗获益：基于长效注射用抗精神病药物, objectType=article, longId=808792, objectId=42f8808e92f9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=42f8808e92f9, replyNumber=0, likeNumber=23, createdTime=2024-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=42f8808e92f9, moduleTitle=CGP医学前沿|精神分裂症的社区治疗获益：基于长效注射用抗精神病药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42f8808e92f9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2180789, encodeId=70bd2180e8941, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a> <a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a> <a href='/topic/show?id=06801098644d' target=_blank style='color:#2F92EE;'>#占诺美林-曲司氯铵#</a>, objectTitle=Lancet：占诺美林-曲司氯铵（KarXT）有望成为新型抗精神病药物（EMERGENT-2试验）, objectType=article, longId=809000, objectId=c1c7809000d9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668025168479_4754896.webp, objectUrl=/article/show_article.do?id=c1c7809000d9, replyNumber=0, likeNumber=24, createdTime=2024-01-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c1c7809000d9, moduleTitle=Lancet：占诺美林-曲司氯铵（KarXT）有望成为新型抗精神病药物（EMERGENT-2试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1c7809000d9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2180541, encodeId=99c92180541b6, content=<a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a> <a href='/topic/show?id=18169695113' target=_blank style='color:#2F92EE;'>#长效阿立哌唑#</a>, objectTitle= Psychiatry Research：通过群体药代动力学模型实现长效阿立哌唑的精准医疗, objectType=article, longId=808853, objectId=63828088535b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696895133889_4754896.jpeg, objectUrl=/article/show_article.do?id=63828088535b, replyNumber=0, likeNumber=20, createdTime=2024-01-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=63828088535b, moduleTitle= Psychiatry Research：通过群体药代动力学模型实现长效阿立哌唑的精准医疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63828088535b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175909, encodeId=52ee21e5909a8, content=<a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a> <a href='/topic/show?id=9d0010886e4c' target=_blank style='color:#2F92EE;'>#首发精神分裂症#</a>, objectTitle=Asian Journal of Psychiatry：首发精神分裂症初治患者抗精神病药物类别的安全性分析：韩国全国性队列研究, objectType=article, longId=805945, objectId=8466805945d6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019563970_4754896.png, objectUrl=/article/show_article.do?id=8466805945d6, replyNumber=0, likeNumber=33, createdTime=2023-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8466805945d6, moduleTitle=Asian Journal of Psychiatry：首发精神分裂症初治患者抗精神病药物类别的安全性分析：韩国全国性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8466805945d6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174506, encodeId=b4ac21e45068f, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a> <a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a>, objectTitle= Br J Psychiatry：精神兴奋剂和托莫西汀治疗精神障碍患者的疗效比较, objectType=article, longId=804762, objectId=8887804e6227, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221115/1668549224601_4754896.webp, objectUrl=/article/show_article.do?id=8887804e6227, replyNumber=0, likeNumber=36, createdTime=2023-12-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8887804e6227, moduleTitle= Br J Psychiatry：精神兴奋剂和托莫西汀治疗精神障碍患者的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8887804e6227)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=917144, encodeId=44bf91e14429, content=<a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a>鼻腔喷入, objectTitle=J Control Release：通过鼻腔喷入的给药方法有望减轻抗精神病药物的副作用, objectType=article, longId=205798, objectId=ca98205e9881, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021116/1610770404234_5121051.png, objectUrl=/article/show_article.do?id=ca98205e9881, replyNumber=0, likeNumber=99, createdTime=2021-01-16, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca98205e9881, moduleTitle=J Control Release：通过鼻腔喷入的给药方法有望减轻抗精神病药物的副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca98205e9881)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗精神病药物

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#抗精神病药物# #血清素# #5-HT2AR#

Mol Psychiatry：抗精神病药物血清素 5-HT2A 受体的药理学指纹

2024-04-08发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#精神分裂症# #抗精神病药物#

CGP医学前沿|精神分裂症的社区治疗获益：基于长效注射用抗精神病药物

2024-01-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#精神分裂症# #抗精神病药物# #占诺美林-曲司氯铵#

Lancet：占诺美林-曲司氯铵（KarXT）有望成为新型抗精神病药物（EMERGENT-2试验）

2024-01-11发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#抗精神病药物# #长效阿立哌唑#

Psychiatry Research：通过群体药代动力学模型实现长效阿立哌唑的精准医疗

2024-01-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#抗精神病药物# #首发精神分裂症#

Asian Journal of Psychiatry：首发精神分裂症初治患者抗精神病药物类别的安全性分析：韩国全国性队列研究

2023-12-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#精神分裂症# #抗精神病药物#

Br J Psychiatry：精神兴奋剂和托莫西汀治疗精神障碍患者的疗效比较

2023-12-12发表于上海

zb1235672 (审核中...)

前往app查看评论内容

#抗精神病药物#鼻腔喷入

J Control Release：通过鼻腔喷入的给药方法有望减轻抗精神病药物的副作用

2021-01-16

科室
- - 订阅+
  - 更多科室
工具
服务